Cell Tissue Res (2016) 366(1):23142
Last Published 10.01.2025 Effective Date: 10.01.2025 This policy addresses the use of white blood cell colony stimulating factors (CSFs), including the drug products Fulphila, Fylnetra, Granix, Leukine, Neulasta, Neupogen, Nivestym, Nyvepria, Releuko, Rolvedon, Stimufend, Udenyca, Zarxio, and Ziextenzo
Special Notes : One of the oldest and most commonly prescribed weight loss medications
At TrimRx, we understand that weight management is not just about losing pounds
Satiety: Including protein in meals and snacks enhances satiety and helps prevent overeating by slowing digestion and prolonging the release of hunger-suppressing hormones like GLP-1
Our studies were reviewed and approved by the Mayo Clinic Institutional Review Board